Key result
Measured 24-hour urine creatinine clearance is linked to ~1% higher odds of extremely low DOAC trough levels.
Why the study?
The accuracy of Cockcroft-Gault-estimated creatinine clearance (eCrCl) for adjusting DOAC doses may be limited in the acute phase of stroke, and direct measurement via 24-hour urine collection (mCrCl) might be a more reliable alternative.
Does creatinine clearance measured from a 24-hour urine collection (mCrCl) better predict steady-state trough plasma levels of direct oral anticoagulants compared to Cockcroft-Gault estimated creatinine clearance (eCrCl) in patients with acute ischemic stroke and atrial fibrillation?
Cohort (n=224)
No
Does creatinine clearance measured from a 24-hour urine collection (mCrCl) better predict steady-state trough plasma levels of direct oral anticoagulants compared to Cockcroft-Gault estimated creatinine clearance (eCrCl) in patients with acute ischemic stroke and atrial fibrillation?
Although the Cockcroft-Gault formula underestimates renal function compared to 24-hour urine collection in acute ischemic stroke patients with AF, both methods similarly predict overall DOAC trough plasma levels, with 24-hour urine CrCl more reliably identifying patients at risk for extremely low DOAC levels.
Answers are grounded in this paper and cite their sources.
Measured creatinine clearance may better identify risk of subtherapeutic DOAC levels; leaves open whether it should supplant Cockcroft-Gault for dosing in acute stroke with AF.
Background Direct oral anticoagulants (DOACs) are excreted partly from the kidneys, and their doses should be adjusted to the renal function, with Cockcroft-Gault-formula being recommended to estimate the creatinine-clearance (eCrCl). Yet the accuracy of this estimation might be limited in the acute phase of stroke. A more reliable alternative might be direct measurement of creatinine-clearance using 24-hour-urine-collection (mCrCl). In this study, the two methods were compared regarding their applicability. Methods Acute ischemic stroke patients with atrial fibrillation under DOAC were enrolled. The trough plasma levels of DOAC were measured during steady state, i.e. 12 ± 1 hours for apixaban and dabigatran, and 24 ± 1 hours for edoxaban and rivaroxaban after the last intake, eCrCl and mCrCl were compared in terms of their ability to predict DOAC-levels using multivariate linear regression analyses and Pearson-tests with comparison using the Fisher's r-to-z transformation. Results 224 patients (106 women, 77.9 ± 8.9 years old, median NIHSS 3) were enrolled. In 67% of cases, mCrCl was higher than eCrCL with mean differences of 10.9 ± 2.0 ml/min. Both eCrCl and mCrCl significantly correlated with the DOAC plasma levels (eCrCl: correlation coefficient=-0.303, P < 0.001; mCrCl: correlation coefficient=-0.294, P < 0.001) and the two correlation coefficients did not differ. High mCrCl was a predictor of extremely low DOAC plasma levels (OR 1.011, 95% CI 1.001–1.022). Conclusions The Cockcroft-Gault-formula seems to underestimate renal function among stroke patients, but differences were relatively low compared to mCrCl. Both mCrCl and eCrCl accurately predicted trough plasma levels of DOAC, still patients with extremely low values are more reliably identified by mCrCl.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) conducted a cohort in Acute ischemic stroke with atrial fibrillation (n=224). Measured creatinine clearance from 24-hour urine collection (mCrCl) vs. Estimated creatinine clearance using Cockcroft-Gault formula (eCrCl) was evaluated on Extremely low trough plasma levels of direct oral anticoagulants (DOACs) (OR 1.011, 95% CI 1.001-1.022, p=0.029). Measured 24-hour urine creatinine clearance independently predicted extremely low DOAC trough levels and correlated similarly with DOAC levels as Cockcroft-Gault.
Synapse has enriched 10 related papers. Consider them for comparative context: